Latest News
Have you Implemented and Tested the 2022 Audit Protocols?
Rethinking Formularies
Model of Care: Evaluate Your Plan’s Evaluation Process!
Rebellis Group is Pleased to Offer a Comprehensive MA and Part D Training Solution
2022 Outlook: Increased Marketing Oversight Is Top MAO Compliance Concern
Rebellis Group is Pleased to Offer a Comprehensive MA and Part D Training Solution
2022 Outlook: Increased Marketing Oversight Is Top MAO Compliance Concern
With more choices than ever, how will your Medicare Advantage Plans stand out in 2023?
With more choices than ever, how will your Medicare Advantage Plans stand out in 2023?
The New Face (to Face) of the SNP Model of Care (MOC)s
Prescription Drug and Health Care Spending
Medicare Advantage and Part D Proposed Rule
Podcast: Supplemental Benefits in Medicare Advantage
An Ounce of Prevention is Worth a Pound of Cure
Prescription Drug and Health Care Spending
Marketing & Sales Misrepresentations
CY2023 Medication Advantage and Part D Proposed Rule (CMS-4192-P) Proposed provisions in this rule
Marketing & Sales Misrepresentations - Detection & Prevention Activities Every MAO Should Implement
Podcast: Supplemental Benefits in Medicare Advantage with Betsy Seals, CEO of the Rebellis Group
Part D Rejected Claims Review: An Ounce of Prevention is Worth a Pound of Cure